BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 24044969)

  • 1. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
    Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo.
    Chiang KC; Yeh CN; Hsu JT; Yeh TS; Jan YY; Wu CT; Chen HY; Jwo SC; Takano M; Kittaka A; Juang HH; Chen TC
    Cell Cycle; 2013 Apr; 12(8):1316-25. PubMed ID: 23549173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
    Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
    J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells.
    Yang SW; Tsai CY; Pan YC; Yeh CN; Pang JH; Takano M; Kittaka A; Juang HH; Chen TC; Chiang KC
    Drug Des Devel Ther; 2016; 10():1995-2002. PubMed ID: 27382252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.
    Chiang KC; Yeh CN; Chen HY; Lee JM; Juang HH; Chen MF; Takano M; Kittaka A; Chen TC
    Steroids; 2011 Dec; 76(13):1513-9. PubMed ID: 21888924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Growth Through Induction of G0/G1 Cell-cycle Arrest and Apoptosis.
    Chiang KC; Yeh CN; Pang JH; Hsu JT; Yeh TS; Chen LW; Kuo SF; Hsieh PJ; Pan YC; Takano M; Chen TC; Feng TH; Kittaka A; Juang HH
    Anticancer Res; 2016 Jul; 36(7):3307-13. PubMed ID: 27354587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
    Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
    Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck.
    Hager G; Formanek M; Gedlicka C; Thurnher D; Knerer B; Kornfehl J
    Acta Otolaryngol; 2001 Jan; 121(1):103-9. PubMed ID: 11270487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.
    Chiang KC; Yeh TS; Huang CC; Chang YC; Juang HH; Cheng CT; Pang JS; Hsu JT; Takano M; Chen TC; Kittaka A; Hsiao M; Yeh CN
    Sci Rep; 2017 Mar; 7():43773. PubMed ID: 28256614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
    Flanagan JN; Zheng S; Chiang KC; Kittaka A; Sakaki T; Nakabayashi S; Zhao X; Spanjaard RA; Persons KS; Mathieu JS; Holick MF; Chen TC
    Anticancer Res; 2009 Sep; 29(9):3547-53. PubMed ID: 19667147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential.
    Chiang KC; Kuo SF; Chen CH; Ng S; Lin SF; Yeh CN; Chen LW; Takano M; Chen TC; Juang HH; Kittaka A; Lin JD; Pang JH
    Cancer Lett; 2015 Dec; 369(1):76-85. PubMed ID: 26282787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma.
    Prudencio J; Akutsu N; Benlimame N; Wang T; Bastien Y; Lin R; Black MJ; Alaoui-Jamali MA; White JH
    J Natl Cancer Inst; 2001 May; 93(10):745-53. PubMed ID: 11353784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
    Chiang KC; Sun CC; Chen MH; Huang CY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Juang HH; Takano M; Kittaka A; Chen TC; Yeh CN; Pang JH
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):26-34. PubMed ID: 26385607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck.
    Gedlicka C; Hager G; Weissenböck M; Gedlicka W; Knerer B; Kornfehl J; Formanek M
    J Oral Pathol Med; 2006 Sep; 35(8):472-8. PubMed ID: 16918598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxyvitamin D
    Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
    Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,25-Dihydroxyvitamin D₃ and cisplatin synergistically induce apoptosis and cell cycle arrest in gastric cancer cells.
    Bao A; Li Y; Tong Y; Zheng H; Wu W; Wei C
    Int J Mol Med; 2014 May; 33(5):1177-84. PubMed ID: 24573222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
    Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
    Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle arrest and apoptosis induced by 1α,25(OH)2D3 and TX 527 in Kaposi sarcoma is VDR dependent.
    González-Pardo V; Suares A; Verstuyf A; De Clercq P; Boland R; de Boland AR
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():197-200. PubMed ID: 24316429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
    J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.